Cambridge Trust’s Carter's CRI Stock Holding History

Cambridge Trust’s Portfolio CRI Stock Details CRI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-23	Closed	-$2K	–	856
2022 Q2	$2K	Buy	+23	New	+$1.85K	﹤0.01%	802
2022 Q1	–	Sell	-1	Closed	–	–	968
2021 Q4	$0	Buy	+1	New	+$102	﹤0.01%	1068

Other funds holding CRI

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

SCM

Shapiro Capital Management Atlanta, Georgia $1.6B AUM 13.27% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Cambridge Trust's CRI Position: Q3 2022 in Review

Cambridge Trust sold out of Carter's (CRI) in Q3 2022, closing a stake of 23 shares — an estimated $2K sold.

Cambridge Trust first reported a position in CRI in Q4 2021 and held it in 2 quarters. The position peaked at $2K in Q2 2022. 299 funds tracked by Wall St. Rank hold CRI as of Q3 2022.

Cambridge Trust reported no remaining Carter's position as of Q3 2022 after selling out during the quarter.
Cambridge Trust sold 23 Carter's shares in Q3 2022, an estimated $2K.
Cambridge Trust first reported a position in Carter's in Q4 2021 and held it in 2 quarters.
Cambridge Trust's Carter's position peaked at $2K in Q2 2022.
299 funds tracked by Wall St. Rank held Carter's as of Q3 2022.

Based on Cambridge Trust's 13F filing for Q3 2022, filed 8 Nov 2022.